C. elegans as model for the study of high glucose-mediated life span reduction

Diabetes

Volumn 58, Issue 11, 2009, Pages 2450-2456

  Schlotterer, Andreas ^a   Kukudov, Georgi ^a   Bozorgmehr, Farastuk ^a   Hutter, Harald ^b   Du, Xueliang ^c   Oikonomou, Dimitrios ^a   Ibrahim, Youssef ^a   Pfisterer, Friederike ^a   Rabbani, Naila ^d   Thornalley, Paul ^d   Sayed, Ahmed ^a   Fleming, Thomas ^a   Humpert, Per ^a   Schwenger, Vedat ^a   Zeier, Martin ^a   Hamann, Andreas ^a,e   Stern, David ^f   Brownlee, Michael ^c   Bierhaus, Angelika ^a   Nawroth, Peter ^a   Morcos, Michael ^a   more..

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b SIMON FRASER UNIVERSITY   (Canada)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e Diabetes Clinic   (Germany)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; LACTOYLGLUTATHIONE LYASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INHIBITION; GLUCOSE INTAKE; GLUCOSE METABOLISM; HYPERGLYCINEMIA; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; GLUCOSE; HUMANS; HYPERGLYCEMIA; LIFE EXPECTANCY; LONGEVITY; MICROSCOPY, ELECTRON, SCANNING; MITOCHONDRIA; REACTIVE OXYGEN SPECIES;

EID: 70350365865     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0567     Document Type: Article

References (19)

1. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptorlike gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997;277:942-946 (Pubitemid 27366677)
2. Phillips SA, Thornalley PJ. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem 1993;212:101-105
3. Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N α-acetylarginine, N α-acetylcysteine, and N α-acetyllysine, and bovine serum albumin. J Biol Chem 1994;269:32299-32305
4. Morcos M, Du X, Pfisterer F, Hutter H, Sayed AA, Thornalley P, Ahmed N, Baynes J, Thorpe S, Kukudov G, Schlotterer A, Bozorgmehr F, El Baki RA, Stern D, Moehrlen F, Ibrahim Y, Oikonomou D, Hamann A, Becker C, Zeier M, Schwenger V, Miftari N, Humpert P, Hammes HP, Buechler M, Bierhaus A, Brownlee M, Nawroth PP. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008;7:260-269
5. Thornalley PJ. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J 1990;269:1-11
6. Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab 2007;6:280-293
7. Racker E. The mechanism of action of glyoxalase. J Biol Chem 1951;190:685-696
8. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond) 1994;87:21-29 (Pubitemid 24220267)
9. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993;366:461-464
10. Rasband WS. ImageJ. http://rsb.info.nih.gov/ij/. U. S. National Institutes of Health, Bethesda, Maryland, 1997
11. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF. A syntaxin 1, G-α (o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 2004;24:4070-4081
12. Timmons L, Fire A. Specific interference by ingested dsRNA. Nature 1998;395:854
13. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003;421:231-237
14. Brownlee M. The pathological implications of protein glycation. Clin Invest Med 1995;18:275-281
15. Brys K, Vanfleteren JR, Braeckman BP. Testing the rate-of-living/ oxidative damage theory of aging in the nematode model Caenorhabditis elegans. Exp Gerontol 2007;42:845-851
16. Lee SS, Kennedy S, Tolonen AC, Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science 2003;300:644-647
17. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 2003;424:277-283
18. McElwee J, Bubb K, Thomas JH. Transcriptional outputs of the Caenorhabditis elegans forkhead protein DAF-16. Aging Cell 2003;2:111-121
19. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559 (Pubitemid 351831356)